Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

The concentric mini-micrografting method is effective for extensive baldness, creating a natural look and efficiently using donor hair.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Stem cells and their surrounding environment in hair follicles work closely together, affecting hair growth and having implications for cancer and tissue regeneration.

Hairless protein is crucial for healthy skin and hair, and its malfunction can cause hair loss.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.

The Hairless gene is crucial for healthy skin and hair growth.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The normal human prostate does not significantly affect blood DHT levels.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Women with AGA have less hair on midscalp, more thin and non-growing hair.

The document concludes that hair follicular unit transplantation is an effective method for eyebrow and eyelash reconstruction, with patients happy despite needing regular trimming.

Densely packed hair grafts can survive well using the lateral slit technique.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Human dermal fibroblasts help microvascular endothelial cells grow, but not vice versa.

Higher epinephrine concentration and specific injection sites increase scalp vasoconstriction time.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

High-density hair transplants can have high survival rates with improved techniques, but lower densities might also give good results.

PCOS may increase the risk of certain cancers.